C
Carlo M. Croce
Researcher at Ohio State University
Publications - 1156
Citations - 199822
Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis
Tetsuya Ueda,Tetsuya Ueda,Stefano Volinia,Stefano Volinia,Hiroshi Okumura,Hiroshi Okumura,Masayoshi Shimizu,Cristian Taccioli,Simona Rossi,Simona Rossi,Hansjuerg Alder,Chang Gong Liu,Chang Gong Liu,Naohide Oue,Wataru Yasui,Kazuhiro Yoshida,Kazuhiro Yoshida,Hiroki Sasaki,Sachiyo Nomura,Yasuyuki Seto,Michio Kaminishi,George A. Calin,Carlo M. Croce +22 more
TL;DR: The relation between microRNA expression and progression and prognosis of gastric cancer and histological subtypes showed different microRNA signatures: eight microRNAs were upregulated in diffuse-type and four in intestinal-type cancer.
Journal ArticleDOI
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation.
Michela Garofalo,Gianpiero Di Leva,Giulia Romano,Gerard J. Nuovo,Sung-Suk Suh,Apollinaire Ngankeu,Cristian Taccioli,Flavia Pichiorri,Hansjuerg Alder,Paola Secchiero,Pierluigi Gasparini,Arianna Gonelli,Stefan Costinean,Mario Acunzo,Gerolama Condorelli,Carlo M. Croce +15 more
TL;DR: It is reported that miR-221&222 are overexpressed in aggressive non-small cell lung cancer and hepatocarcinoma cells, as compared with less invasive and/or normal lung and liver cells, and it is demonstrated that the MET oncogene is involved in miR+222 activation through the c-Jun transcription factor.
Journal ArticleDOI
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior
Claudia Roldo,Edoardo Missiaglia,John P. Hagan,Massimo Falconi,Paola Capelli,Samantha Bersani,George A. Calin,Stefano Volinia,Chang Gong Liu,Aldo Scarpa,Carlo M. Croce +10 more
TL;DR: Results suggest that alteration in microRNA expression is related to endocrine and acinar neoplastic transformation and progression of malignancy, and might prove useful in distinguishing tumors with different clinical behavior.
Journal ArticleDOI
MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer
Junfang Ji,Jiong Shi,Jiong Shi,Anuradha Budhu,Zhipeng Yu,Marshonna Forgues,Stephanie Roessler,Stefan Ambs,Yi Chen,Paul S. Meltzer,Carlo M. Croce,Lun Xiu Qin,Kwan Man,Chung Mau Lo,Joyce Man-Fong Lee,Irene Oi-Lin Ng,Jia Fan,Zhao-You Tang,Hui-Chuan Sun,Xin Wei Wang +19 more
TL;DR: The expression patterns of microRNAs in liver tissue differ between men and women with hepatocellular carcinoma, and the miR-26 expression status of such patients is associated with survival and response to adjuvant therapy with interferon alfa.
Journal ArticleDOI
MicroRNA expression and function in cancer
TL;DR: Large high-throughput studies in patients revealed that miRNA profiling have the potential to classify tumors with high accuracy and predict outcome and the role of miRNAs in the pathogenesis of cancer is examined.